Page last updated: 2024-09-04

cycloastragenol and Cryptogenic Fibrosing Alveolitis

cycloastragenol has been researched along with Cryptogenic Fibrosing Alveolitis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahuja, SS; Allsopp, R; Brampton, C; Davy, P; Fauce, S; Harley, CB; Le Saux, CJ; Nguyen, H; Pirot, Z; Ramaseshan, M; Shivshankar, P; Tressler, R	1

Other Studies

1 other study(ies) available for cycloastragenol and Cryptogenic Fibrosing Alveolitis

Article	Year
A novel telomerase activator suppresses lung damage in a murine model of idiopathic pulmonary fibrosis. PloS one, 2013, Volume: 8, Issue:3 Topics: Alveolar Epithelial Cells; Animals; Bleomycin; Cellular Senescence; Collagen; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activators; Fibroblasts; Humans; Idiopathic Pulmonary Fibrosis; Inflammation; Lung; Mice; Respiratory Mucosa; Sapogenins; Telomerase	2013

Article

Year

A novel telomerase activator suppresses lung damage in a murine model of idiopathic pulmonary fibrosis.

PloS one, 2013, Volume: 8, Issue:3

Topics: Alveolar Epithelial Cells; Animals; Bleomycin; Cellular Senescence; Collagen; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activators; Fibroblasts; Humans; Idiopathic Pulmonary Fibrosis; Inflammation; Lung; Mice; Respiratory Mucosa; Sapogenins; Telomerase

2013